Glow 70mg

GLOW 70mg is a multi-compound research blend combining GHK-Cu (50mg), TB-500 (10mg) and BPC-157 (10mg) in a single co-lyophilised vial at ≥99% purity per compound. Formulated for multi-pathway regenerative and skin-research protocols studying copper-peptide and repair-peptide signalling together.

For laboratory research use only.

GLOW 70mg is a multi-compound research blend combining three of the most widely studied regenerative and repair peptides in a single co-lyophilised vial at ≥99% purity per compound. The blend pairs GHK-Cu (50mg) — the copper-binding tripeptide studied for skin, collagen and tissue-remodelling research — with BPC-157 (10mg) and TB-500 (10mg), two compounds widely investigated for repair and regenerative signalling.

The GLOW composition is selected by researchers studying the combined effects of copper-peptide and repair-peptide pathways within a single preparation. Each batch is HPLC-verified to ≥99% per compound. With next day dispatch,

For laboratory research use only.

RESEARCH CONTEXT

The GLOW blend brings together three complementary research compounds:

• GHK-Cu (50mg) — A copper-binding tripeptide studied extensively in skin, collagen-synthesis, wound-remodelling and extracellular-matrix research
• BPC-157 (10mg) — A synthetic peptide studied for gastrointestinal, tendon and connective-tissue repair signalling in vitro
• TB-500 (10mg) — A synthetic fragment of Thymosin Beta-4 studied for cell migration, angiogenesis and tissue-repair pathways

Combining the three in one vial allows researchers to investigate potential multi-pathway interactions between copper-peptide and regenerative-peptide signalling within matched experimental conditions.

Glow Research Review 

PRODUCT SPECIFICATIONS